Literature DB >> 27865282

Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer.

George Younan1, Susan Tsai1, Douglas B Evans1, Kathleen K Christians2.   

Abstract

Multimodality therapy has become the standard approach for the treatment of pancreatic cancer. With improved response rates to newer chemotherapeutic agents, tumors that used to be considered unresectable are now being considered for operation. Neoadjuvant therapy for borderline resectable pancreatic cancer is considered standard of care and venous resection/reconstruction is no longer controversial. Arterial resection and reconstruction in select patients has also proven to be safe when done in highly specialized centers by high-volume surgeons. This article reviews indications for, and technical aspects of, vascular resection/reconstruction and shunting procedures during pancreatectomy, including critical elements of perioperative care.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pancreaticoduodenectomy; Vascular reconstruction; Vascular resection; Whipple

Mesh:

Year:  2016        PMID: 27865282     DOI: 10.1016/j.suc.2016.07.005

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  10 in total

Review 1.  Pancreaticoduodenectomy with Replaced Common Hepatic Artery and Portal Vein Reconstruction in Primary Carcinoma Duodenum: a Case Report and Literature Review.

Authors:  Gunjan S Desai; Prasad Pande; Rajiv C Shah; Palepu Jagannath
Journal:  J Gastrointest Cancer       Date:  2019-09

Review 2.  Prepancreatic common hepatic artery arising from superior mesenteric artery: an exceptional but important finding during pancreaticoduodenectomy.

Authors:  Lorenzo Cinelli; Eric Felli; Edoardo Maria Muttillo; Guido Fiorentini; Michele Diana; Patrick Pessaux; Emanuele Felli
Journal:  Surg Radiol Anat       Date:  2021-06-12       Impact factor: 1.246

Review 3.  Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer.

Authors:  William A Hall; Beth Erickson; Christopher H Crane
Journal:  Surg Oncol Clin N Am       Date:  2021-10       Impact factor: 2.402

4.  Parachute technique for portal vein reconstruction during pancreaticoduodenectomy with portal vein resection in patients with pancreatic head cancer.

Authors:  Shoichi Irie; Ryuji Yoshioka; Hiroshi Imamura; Yoshihiro Ono; Takafumi Sato; Yosuke Inoue; Hiromichi Ito; Yoshihiro Mise; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2021-10-19       Impact factor: 2.895

Review 5.  Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement.

Authors:  Amy Y Li; Brendan C Visser; Monica M Dua
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

6.  Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

Authors:  Rebecca Y Kim; Kathleen K Christians; Mohammed Aldakkak; Callisia N Clarke; Ben George; Mandana Kamgar; Abdul H Khan; Naveen Kulkarni; William A Hall; Beth A Erickson; Douglas B Evans; Susan Tsai
Journal:  Ann Surg Oncol       Date:  2020-09-30       Impact factor: 5.344

7.  Arterial resection and reconstruction in pancreatectomy: surgical technique and outcomes.

Authors:  Qiyi Zhang; Jingjin Wu; Yang Tian; Jixuan Duan; Yi Shao; Sheng Yan; Weilin Wang
Journal:  BMC Surg       Date:  2019-10-10       Impact factor: 2.102

8.  Risk factors for early morbidity and mortality following pancreatoduodenectomy with concomitant vascular reconstruction.

Authors:  Tiffany Y Lim; I Michael Leitman
Journal:  Ann Med Surg (Lond)       Date:  2021-07-27

9.  Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma.

Authors:  Yugal Limbu; Sujan Regmee; Roshan Ghimire; Dhiresh Kumar Maharjan; Prabin Bikram Thapa
Journal:  Cureus       Date:  2021-12-08

10.  Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis.

Authors:  Lai Wang; Chien-Shan Cheng; Lianyu Chen; Zhen Chen
Journal:  Cancer Manag Res       Date:  2018-07-05       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.